Ajax-Loading

Chugai Pharmaceutical Co. Ltd. - Net Income

Chugai Pharmaceutical Co. Ltd.'s Fiscal Year is From January To December - All Figures are in JPY, Billions.

The item "Net-Income" stands at 395.48 Billion Japanese Yens for the trailing twelve months (TTM) period ending 06/30/2025.

Chugai Pharmaceutical Co. Ltd.'s second quarter result of 97.16 Billion JPY for the item "Net Income" represents a decrease of -0.08 percent compared to it's first quarter result.

Also, Chugai Pharmaceutical Co. Ltd.'s second quarter result of 97.16 Billion JPY for the item "Net Income" represents a decrease of -13.15 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Chugai Pharmaceutical Co. Ltd.'s second quarter result of 395.48 Billion JPY for the item "Net Income" represents a decrease of -3.58 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 11.39 percent compared to the value the year prior.
The 1 year change in percent is 11.39.
The 3 year change in percent is 1.66.
The 5 year change in percent is 107.50.
The 10 year change in percent is 657.33.

The Serie's long term average value is 162.54 Billion Japanese Yens. It's latest available value, on 06/30/2025, is 143.31 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2011, to it's latest available value, on 06/30/2025, is +1,022.48%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 06/30/2025, is -3.58%.

Net Income for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Net Income905,699,262,464.00
LogoJohnson & Johnson - Net Income486,508,953,600.00
LogoAbbVie Inc - Net Income399,570,305,024.00
LogoRoche Holding AG - Net Income317,433,206,677.55
LogoAstraZeneca PLC - Net Income280,205,508,085.11